Panel Discussion: Why China, Why Now? Evaluating the Opportunities, Risks & Realities of Operating in China
12:00 pm - Tuesday 9th February 2027
- Assessing the advantages and trade-offs of Chinese development and manufacturing, to determine the optimal balance between speed, cost, quality, effort, and long-term clinical strategy
- Navigating IIT pathways and regulatory requirements to support future clinical and regulatory success in Asia, the US and Europe
- Examining the investment and commercial implications of conducting trials and manufacturing in China, to accelerate asset interest and global market opportunities
